CoChat

α-Synuclein fibrils subvert lysosome structure and function for the propagation of protein misfolding between cells through tunneling nanotubes

Open access
Dilsizoglu Senol, Aysegul, Samarani, Maura, Syan, Sylvie, Guardia, Carlos M., Nonaka, Takashi, Liv, Nalan, Latour-Lambert, Patricia, Hasegawa, Masato, Klumperman, Judith, Bonifacino, Juan S., Zurzolo, Chiara · 2021 · PLOS Biology

The DOI matches its Crossref record; 143 of the 144 references it cites were found in a registry or an index, and 1 are not checked yet.

Abstract

The accumulation of α-synuclein (α-syn) aggregates in specific brain regions is a hallmark of synucleinopathies including Parkinson disease (PD). α-Syn aggregates propagate in a “prion-like” manner and can be transferred inside lysosomes to recipient cells through tunneling nanotubes (TNTs). However, how lysosomes participate in the spreading of α-syn aggregates is unclear. Here, by using super-resolution (SR) and electron microscopy (EM), we find that α-syn fibrils affect the morphology of lysosomes and impair their function in neuronal cells. In addition, we demonstrate that α-syn fibrils induce peripheral redistribution of lysosomes, likely mediated by transcription factor EB (TFEB), increasing the efficiency of α-syn fibrils’ transfer to neighboring cells. We also show that lysosomal membrane permeabilization (LMP) allows the seeding of soluble α-syn in cells that have taken up α-syn fibrils from the culture medium, and, more importantly, in healthy cells in coculture, following lysosome-mediated transfer of the fibrils. Moreover, we demonstrate that seeding occurs mainly at lysosomes in both donor and acceptor cells, after uptake of α-syn fibrils from the medium and following their transfer, respectively. Finally, by using a heterotypic coculture system, we determine the origin and nature of the lysosomes transferred between cells, and we show that donor cells bearing α-syn fibrils transfer damaged lysosomes to acceptor cells, while also receiving healthy lysosomes from them. These findings thus contribute to the elucidation of the mechanism by which α-syn fibrils spread through TNTs, while also revealing the crucial role of lysosomes, working as a Trojan horse for both seeding and propagation of disease pathology.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pbio.3001287

Cites

143 of 144 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 α-Syn fibrils affect the morphology of lysosomes. (A) Representative confocal images of control and Alexa 568–tagged α-syn fibril-treated (18 hours) CAD cells, immunolabeled for LAMP1 (green). Colocalization between LAMP1+ puncta and α-syn fibrils is indicated by arrows in the inset of a selected region delimited by a square. % of α-syn fibrils colocalizing with LAMP1+ puncta (74 ± 1%) and % of LAMP1+ puncta colocalizing with α-syn fibrils (60 ± 1%) performed by object-based 3D colocalization method (Imaris software) is presented. Mean ± SEM, n = 3 (30 cells per condition). Scale bar: 10 μm (for inset: 2 μm). (B) SR images of control (left panel) and Alexa 568–tagged α-syn fibril-treated CAD cells for 18 hours (right panel), immunolabeled for LAMP1 (far-red) antibody (pseudo colored in gray). Merge images of each condition are presented with additional HCS CellMask Blue staining. Magenta and green arrows indicate the selected lysosomes having α-syn fibrils inside the lysosomal lumen and on the lysosomal membrane, respectively, where higher magnifications of these lysosomes and 3D reconstructions are represented in magenta and green squares, respectively. Scale bar: 10 μm (for insets: 2 μm, for magenta and green insets: 0.5 μm). Average diameter (μm) of lysosomes in control (0.43 ± 0.01) and in α-syn fibril-treated cells, the latter subgrouped as the following: Lysosomes without α-syn fibrils (0.43 ± 0.01) and lysosomes with α-syn fibrils (0.63 ± 0.01) are presented. Mean ± SEM, lysosomes’ diameters were measured in SR images of 8 α-syn fibril-treated cells and 7 control cells (155 lysosomes per condition). Images were acquired by spinning disk microscopy with SR module. ns = not significant, ****P < 0.0001 by Kruskal–Wallis nonparametric ANOVA test followed by Dunn multiple comparison tests. (C) FM image of LAMP1-GFP transfected and α-syn fibril-treated CAD cells for 18 hours (left panel). Enlarged merged images of correlative resin EM and FM images of 4 selected lysosomes not containing (number 1, indicated by green square) and containing α-syn fibrils (numbers 2, 3, and 4, indicated by red squares) are presented. Lysosomes number 1 and 2 are further magnified (blue squares) and presented within the same image. Scale bar: 10 μm (for red and green insets: 0.5 μm, for blue insets: 0.2 μm). (D) Overlay of on-section correlative EM images immunogold labeled for LAMP110 and FM images of LAMP1-GFP transfected and α-syn fibril-treated CAD cells (18 hours). Insets of 3 selected regions (indicated by red, purple, and black squares) are presented. Average perimeter (μm) of lysosomes in control (1.16 ± 0.04) and in α-syn fibril-treated cells: Lysosomes without α-syn fibrils (1.16 ± 0.06) and lysosomes with α-syn fibrils (2.24 ± 0.14; upper graph) are presented. ns = not significant, ****P < 0.0001 by 1-way ANOVA followed by Tukey multiple comparison tests. Average area (μm2) of lysosomes in control (0.08 ± 0.01) and in α-syn fibril-treated cells: Lysosomes without α-syn fibrils (0.08 ± 0.01) and lysosomes with α-syn fibrils (0.16 ± 0.01; lower graph) are presented. Mean ± SEM (50 cells per condition). ns = not significant, ****P < 0.0001 by Kruskal–Wallis nonparametric ANOVA test followed by Dunn multiple comparison tests. Scale bar: 10 μm (for insets: 0.5 μm). The data underlying this figure may be found in S1 Data. α-syn, α-synuclein; CAD, Cath.a-differentiated; EM, electron microscopy; FM, fluorescence microscopy; LAMP, lysosome-associated membrane protein; LD, lipid droplet; Lyso and lys, lysosome; PM, plasma membrane; SR, super-resolution; TEM, transmission electron microscopy.
Fig 1 α-Syn fibrils affect the morphology of lysosomes. (A) Representative confocal images of control and Alexa 568–tagged α-syn fibril-treated (18 hours) CAD cells, immunolabeled for LAMP1 (green). Colocalization between LAMP1+ puncta and α-syn fibrils is indicated by arrows in the inset of a selected region delimited by a square. % of α-syn fibrils colocalizing with LAMP1+ puncta (74 ± 1%) and % of LAMP1+ puncta colocalizing with α-syn fibrils (60 ± 1%) performed by object-based 3D colocalization method (Imaris software) is presented. Mean ± SEM, n = 3 (30 cells per condition). Scale bar: 10 μm (for inset: 2 μm). (B) SR images of control (left panel) and Alexa 568–tagged α-syn fibril-treated CAD cells for 18 hours (right panel), immunolabeled for LAMP1 (far-red) antibody (pseudo colored in gray). Merge images of each condition are presented with additional HCS CellMask Blue staining. Magenta and green arrows indicate the selected lysosomes having α-syn fibrils inside the lysosomal lumen and on the lysosomal membrane, respectively, where higher magnifications of these lysosomes and 3D reconstructions are represented in magenta and green squares, respectively. Scale bar: 10 μm (for insets: 2 μm, for magenta and green insets: 0.5 μm). Average diameter (μm) of lysosomes in control (0.43 ± 0.01) and in α-syn fibril-treated cells, the latter subgrouped as the following: Lysosomes without α-syn fibrils (0.43 ± 0.01) and lysosomes with α-syn fibrils (0.63 ± 0.01) are presented. Mean ± SEM, lysosomes’ diameters were measured in SR images of 8 α-syn fibril-treated cells and 7 control cells (155 lysosomes per condition). Images were acquired by spinning disk microscopy with SR module. ns = not significant, ****P < 0.0001 by Kruskal–Wallis nonparametric ANOVA test followed by Dunn multiple comparison tests. (C) FM image of LAMP1-GFP transfected and α-syn fibril-treated CAD cells for 18 hours (left panel). Enlarged merged images of correlative resin EM and FM images of 4 selected lysosomes not containing (number 1, indicated by green square) and containing α-syn fibrils (numbers 2, 3, and 4, indicated by red squares) are presented. Lysosomes number 1 and 2 are further magnified (blue squares) and presented within the same image. Scale bar: 10 μm (for red and green insets: 0.5 μm, for blue insets: 0.2 μm). (D) Overlay of on-section correlative EM images immunogold labeled for LAMP110 and FM images of LAMP1-GFP transfected and α-syn fibril-treated CAD cells (18 hours). Insets of 3 selected regions (indicated by red, purple, and black squares) are presented. Average perimeter (μm) of lysosomes in control (1.16 ± 0.04) and in α-syn fibril-treated cells: Lysosomes without α-syn fibrils (1.16 ± 0.06) and lysosomes with α-syn fibrils (2.24 ± 0.14; upper graph) are presented. ns = not significant, ****P < 0.0001 by 1-way ANOVA followed by Tukey multiple comparison tests. Average area (μm2) of lysosomes in control (0.08 ± 0.01) and in α-syn fibril-treated cells: Lysosomes without α-syn fibrils (0.08 ± 0.01) and lysosomes with α-syn fibrils (0.16 ± 0.01; lower graph) are presented. Mean ± SEM (50 cells per condition). ns = not significant, ****P < 0.0001 by Kruskal–Wallis nonparametric ANOVA test followed by Dunn multiple comparison tests. Scale bar: 10 μm (for insets: 0.5 μm). The data underlying this figure may be found in S1 Data. α-syn, α-synuclein; CAD, Cath.a-differentiated; EM, electron microscopy; FM, fluorescence microscopy; LAMP, lysosome-associated membrane protein; LD, lipid droplet; Lyso and lys, lysosome; PM, plasma membrane; SR, super-resolution; TEM, transmission electron microscopy.CC0 · PubMed Central
Fig 2 α-Syn fibrils affect the function of lysosomes. (A) Average number of lysosomes (LAMP1+ puncta) per cell in control (222 ± 6) and in α-syn fibril-treated CAD cells for 18 hours (218 ± 7) is presented. Mean ± SEM, n = 5 (50 cells per condition). ns = not significant by Whitney–Mann U test (left panel). Western blot showing LAMP1 and α-tubulin expression in control and α-syn fibril-treated cells. Integrated density of LAMP1 protein expression levels normalized to α-tubulin in control (0.9 ± 0.2) and α-syn fibril-treated cells (0.7 ± 0.1) are presented in AU. Mean ± SEM, n = 3. ns = not significant by paired t test. (B) Representative confocal images of control and Alexa 568–tagged α-syn fibrils challenged CAD cells (18 hours), labeled with LysoTracker DR (20 nM for 20 minutes; LysoTracker DR is pseudo colored in gray). Dashed lines represent the cell contour. Average integrated density of control cells (1.4 × 107 ± 9 × 105) and α-syn fibril-treated cells (8.3 × 106 ± 5 × 105) is presented. Mean ± SEM, n = 3 (40 cells per condition). ****P < 0.0001 by Mann–Whitney U test. Scale bar: 10 μm. (C) Representative confocal images of control and Alexa 568–tagged α-syn fibrils (red) challenged CAD cells for 18 hours, treated with DQ-BSA (green) for 90 minutes. Dashed lines represent the cell contour. Average integrated density measured for control cells (3.8 × 106 ± 1 × 105) and α-syn fibril-treated cells (1.7 × 106 ± 6 × 104) is presented. Mean ± SEM, n = 3 (25 cells per condition). ****P < 0.0001 by Mann–Whitney U test. Scale bar: 10 μm. (D) Representative confocal images of control and Alexa 488-tagged α-syn fibrils (green) challenged CAD cells for 18 hours treated with 1X Magic Red CathB (red). Dashed lines represent the cell contour. Average integrated density measured for control cells (1.3 × 106 ± 6 × 104) and α-syn fibril-treated cells (7.5 × 105 ± 5 × 104) is presented. Mean ± SEM, n = 5 (100 cells per condition). ****P < 0.0001 by Mann–Whitney U test. Scale bar: 10 μm. The data underlying this figure may be found in S1 Data. α-syn, α-synuclein; AU, arbitrary unit; CAD, Cath.a-differentiated; CathB, Cathepsin B; LAMP, lysosome-associated membrane protein; LysoTracker DR, LysoTracker Deep Red.
Fig 2 α-Syn fibrils affect the function of lysosomes. (A) Average number of lysosomes (LAMP1+ puncta) per cell in control (222 ± 6) and in α-syn fibril-treated CAD cells for 18 hours (218 ± 7) is presented. Mean ± SEM, n = 5 (50 cells per condition). ns = not significant by Whitney–Mann U test (left panel). Western blot showing LAMP1 and α-tubulin expression in control and α-syn fibril-treated cells. Integrated density of LAMP1 protein expression levels normalized to α-tubulin in control (0.9 ± 0.2) and α-syn fibril-treated cells (0.7 ± 0.1) are presented in AU. Mean ± SEM, n = 3. ns = not significant by paired t test. (B) Representative confocal images of control and Alexa 568–tagged α-syn fibrils challenged CAD cells (18 hours), labeled with LysoTracker DR (20 nM for 20 minutes; LysoTracker DR is pseudo colored in gray). Dashed lines represent the cell contour. Average integrated density of control cells (1.4 × 107 ± 9 × 105) and α-syn fibril-treated cells (8.3 × 106 ± 5 × 105) is presented. Mean ± SEM, n = 3 (40 cells per condition). ****P < 0.0001 by Mann–Whitney U test. Scale bar: 10 μm. (C) Representative confocal images of control and Alexa 568–tagged α-syn fibrils (red) challenged CAD cells for 18 hours, treated with DQ-BSA (green) for 90 minutes. Dashed lines represent the cell contour. Average integrated density measured for control cells (3.8 × 106 ± 1 × 105) and α-syn fibril-treated cells (1.7 × 106 ± 6 × 104) is presented. Mean ± SEM, n = 3 (25 cells per condition). ****P < 0.0001 by Mann–Whitney U test. Scale bar: 10 μm. (D) Representative confocal images of control and Alexa 488-tagged α-syn fibrils (green) challenged CAD cells for 18 hours treated with 1X Magic Red CathB (red). Dashed lines represent the cell contour. Average integrated density measured for control cells (1.3 × 106 ± 6 × 104) and α-syn fibril-treated cells (7.5 × 105 ± 5 × 104) is presented. Mean ± SEM, n = 5 (100 cells per condition). ****P < 0.0001 by Mann–Whitney U test. Scale bar: 10 μm. The data underlying this figure may be found in S1 Data. α-syn, α-synuclein; AU, arbitrary unit; CAD, Cath.a-differentiated; CathB, Cathepsin B; LAMP, lysosome-associated membrane protein; LysoTracker DR, LysoTracker Deep Red.CC0 · PubMed Central
Fig 3 α-Syn fibrils induce LMP. (A) Representative confocal images of Gal3-GFP transfected control (upper panel) and Alexa 568–tagged α-syn fibril-treated CAD cells for 18 hours (lower panel), labeled with LAMP1-Alexa 647 antibody (pseudo colored in gray). Higher magnifications of the selected region in α-syn fibril-treated cells (white squares) are presented on the upper left part of each image. Arrowheads indicate a lysosome having α-syn fibrils colocalizing with Gal3 puncta. Scale bar: 10 μm (for insets: 5 μm). (B) % of control (7 ± 1%) and α-syn fibril-treated CAD cells for 18 hours (46 ± 2%) under LMP (left graph), and average number of Gal3-GFP puncta for control (8 ± 1) and α-syn fibril-treated cells (12 ± 1) under LMP (right graph). Mean ± SEM, n = 3 (50 cells per condition). ****P < 0.0001 by Mann–Whitney U test. (C) % of Gal3-GFP puncta colocalizing with α-syn fibrils (38 ± 4%), with LAMP1 (47 ± 3%) and with both α-syn fibrils and LAMP1 (35 ± 3%) calculated by object-based 3D colocalization (Imaris software). Mean ± SEM, n = 3 (30 cells per condition). (D) SR image showing the recruitment of Gal3-GFP to a lysosome containing α-syn fibrils puncta in its lumen. (E) SR image showing the recruitment of Gal3-GFP to a lysosome having α-syn fibrils at its membrane. In D and E, insets of 2 selected regions (white squares) from different Z-planes of the same Gal3-GFP transfected and α-syn fibril-treated CAD cell, labeled for HCS CellMask Blue, DAPI, and LAMP1 (pseudo colored in gray) are presented. Images were acquired with SR SIM (Zeiss, LSM 780-Elyra PS.1). Scale bars: 10 μm (for insets: 1 μm). The data underlying this figure may be found in S1 Data. α-syn, α-synuclein; Gal3, Galectin-3; CAD, Cath.a-differentiated; LAMP, lysosome-associated membrane protein; LMP, lysosomal membrane permeabilization; SIM, structured illumination microscopy; SR, super-resolution.
Fig 3 α-Syn fibrils induce LMP. (A) Representative confocal images of Gal3-GFP transfected control (upper panel) and Alexa 568–tagged α-syn fibril-treated CAD cells for 18 hours (lower panel), labeled with LAMP1-Alexa 647 antibody (pseudo colored in gray). Higher magnifications of the selected region in α-syn fibril-treated cells (white squares) are presented on the upper left part of each image. Arrowheads indicate a lysosome having α-syn fibrils colocalizing with Gal3 puncta. Scale bar: 10 μm (for insets: 5 μm). (B) % of control (7 ± 1%) and α-syn fibril-treated CAD cells for 18 hours (46 ± 2%) under LMP (left graph), and average number of Gal3-GFP puncta for control (8 ± 1) and α-syn fibril-treated cells (12 ± 1) under LMP (right graph). Mean ± SEM, n = 3 (50 cells per condition). ****P < 0.0001 by Mann–Whitney U test. (C) % of Gal3-GFP puncta colocalizing with α-syn fibrils (38 ± 4%), with LAMP1 (47 ± 3%) and with both α-syn fibrils and LAMP1 (35 ± 3%) calculated by object-based 3D colocalization (Imaris software). Mean ± SEM, n = 3 (30 cells per condition). (D) SR image showing the recruitment of Gal3-GFP to a lysosome containing α-syn fibrils puncta in its lumen. (E) SR image showing the recruitment of Gal3-GFP to a lysosome having α-syn fibrils at its membrane. In D and E, insets of 2 selected regions (white squares) from different Z-planes of the same Gal3-GFP transfected and α-syn fibril-treated CAD cell, labeled for HCS CellMask Blue, DAPI, and LAMP1 (pseudo colored in gray) are presented. Images were acquired with SR SIM (Zeiss, LSM 780-Elyra PS.1). Scale bars: 10 μm (for insets: 1 μm). The data underlying this figure may be found in S1 Data. α-syn, α-synuclein; Gal3, Galectin-3; CAD, Cath.a-differentiated; LAMP, lysosome-associated membrane protein; LMP, lysosomal membrane permeabilization; SIM, structured illumination microscopy; SR, super-resolution.CC0 · PubMed Central
Fig 4 α-Syn fibrils seed de novo formation of aggregates associated with lysosomes. (A) Representative confocal images of α-syn-GFP transfected control or Alexa 568–tagged α-syn fibril-treated CAD cells (18 hours). Scale bar: 10 μm (for insets: 5 μm). (B) % of control (13 ± 2%) and α-syn fibril-treated CAD cells for 18 hours (76 ± 5%) that formed α-syn-GFP aggregates (left graph). Mean ± SEM, n = 3 (45 cells per condition). ****P < 0.0001 by 2-tailed t test. Average number of α-syn-GFP puncta per cell in control (12 ± 1) and α-syn fibril-treated cells (27 ± 3) (right graph). Mean ± SEM, n = 3 (45 cells per condition). **P = 0.005 by Mann–Whitney U test. (C) SR image showing α-syn fibrils puncta and α-syn-GFP+ aggregate colocalizing on the lysosomal membrane in CAD cells treated with α-syn fibrils for 18 hours. (D) SR image showing colocalization between α-syn fibrils puncta and α-syn-GFP+ aggregate inside the lysosomal lumen and α-syn fibrils on the lysosomal membrane in CAD cells treated with α-syn fibrils for 18 hours. (E) SR image showing α-syn fibrils puncta and α-syn-GFP+ aggregate inside the lysosomal lumen in CAD cells treated with α-syn fibrils for 18 hours. (F) Object-based 3D colocalization analysis (Imaris software) between α-syn-GFP aggregates and α-syn fibrils (74 ± 7%), α-syn-GFP aggregates and LAMP1+ lysosomes (69 ± 6%), and α-syn-GFP aggregates with both α-syn fibrils and LAMP1+ lysosomes (63 ± 6%). Mean ± SEM, n = 2 (16 SR images, approximately 2,000 lysosomes were analyzed). (G) SR image showing α-syn fibrils puncta and α-syn-GFP+ aggregate colocalizing with LAMP1 on the lysosomal membrane in CAD cells treated with α-syn fibrils for 1 hour. (H) SR image demonstrating α-syn fibrils puncta and α-syn-GFP+ aggregate colocalizing with LAMP1 both on the lysosomal membrane and inside the lysosomal lumen in CAD cells treated with α-syn fibrils for 2 hours. (I) SR image showing α-syn fibrils puncta and α-syn-GFP+ aggregate colocalizing with LAMP1 on the lysosomal membrane in CAD cells treated with α-syn fibrils for 4 hours. In C, D, E, G, H, and I insets of selected regions (white squares) from different α-syn-GFP transfected and α-syn fibril-treated CAD cells, labeled for DAPI and LAMP1 (pseudo colored in gray) are presented. Images were acquired with a spinning disk microscope with SR module. Scale bars: 10 μm (for insets: 1 μm; 0.5 μm for inset in G). The data underlying this figure may be found in S1 Data. α-syn, α-synuclein; CAD, Cath.a-differentiated; LAMP, lysosome-associated membrane protein; SR, super-resolution.
Fig 4 α-Syn fibrils seed de novo formation of aggregates associated with lysosomes. (A) Representative confocal images of α-syn-GFP transfected control or Alexa 568–tagged α-syn fibril-treated CAD cells (18 hours). Scale bar: 10 μm (for insets: 5 μm). (B) % of control (13 ± 2%) and α-syn fibril-treated CAD cells for 18 hours (76 ± 5%) that formed α-syn-GFP aggregates (left graph). Mean ± SEM, n = 3 (45 cells per condition). ****P < 0.0001 by 2-tailed t test. Average number of α-syn-GFP puncta per cell in control (12 ± 1) and α-syn fibril-treated cells (27 ± 3) (right graph). Mean ± SEM, n = 3 (45 cells per condition). **P = 0.005 by Mann–Whitney U test. (C) SR image showing α-syn fibrils puncta and α-syn-GFP+ aggregate colocalizing on the lysosomal membrane in CAD cells treated with α-syn fibrils for 18 hours. (D) SR image showing colocalization between α-syn fibrils puncta and α-syn-GFP+ aggregate inside the lysosomal lumen and α-syn fibrils on the lysosomal membrane in CAD cells treated with α-syn fibrils for 18 hours. (E) SR image showing α-syn fibrils puncta and α-syn-GFP+ aggregate inside the lysosomal lumen in CAD cells treated with α-syn fibrils for 18 hours. (F) Object-based 3D colocalization analysis (Imaris software) between α-syn-GFP aggregates and α-syn fibrils (74 ± 7%), α-syn-GFP aggregates and LAMP1+ lysosomes (69 ± 6%), and α-syn-GFP aggregates with both α-syn fibrils and LAMP1+ lysosomes (63 ± 6%). Mean ± SEM, n = 2 (16 SR images, approximately 2,000 lysosomes were analyzed). (G) SR image showing α-syn fibrils puncta and α-syn-GFP+ aggregate colocalizing with LAMP1 on the lysosomal membrane in CAD cells treated with α-syn fibrils for 1 hour. (H) SR image demonstrating α-syn fibrils puncta and α-syn-GFP+ aggregate colocalizing with LAMP1 both on the lysosomal membrane and inside the lysosomal lumen in CAD cells treated with α-syn fibrils for 2 hours. (I) SR image showing α-syn fibrils puncta and α-syn-GFP+ aggregate colocalizing with LAMP1 on the lysosomal membrane in CAD cells treated with α-syn fibrils for 4 hours. In C, D, E, G, H, and I insets of selected regions (white squares) from different α-syn-GFP transfected and α-syn fibril-treated CAD cells, labeled for DAPI and LAMP1 (pseudo colored in gray) are presented. Images were acquired with a spinning disk microscope with SR module. Scale bars: 10 μm (for insets: 1 μm; 0.5 μm for inset in G). The data underlying this figure may be found in S1 Data. α-syn, α-synuclein; CAD, Cath.a-differentiated; LAMP, lysosome-associated membrane protein; SR, super-resolution.CC0 · PubMed Central
Fig 5 α-Syn–loaded lysosomes localize to the cell periphery, are less functional, and are preferentially transferred to neighboring cells. (A) Representative confocal images of control and Alexa 568–tagged α-syn fibril-treated CAD cells (18 hours) labeled for LAMP1-Alexa 488 antibody, HCS CellMask Blue, and DAPI. White arrows indicate the perinuclear lysosome clusters in control cells; green, red, and yellow arrows indicate peripheral lysosomes, α-syn fibrils, and lysosomes colocalizing with α-syn fibrils, respectively. Scale bar: 10 μm. (B) % of LAMP1+ lysosomes in perinuclear (purple dots) and peripheral regions (black dots) of the control cells and cells challenged with α-syn fibrils is presented. In control cells: % of perinuclear lysosomes: 57 ± 1%, and peripheral lysosomes: 43 ± 1%; in α-syn fibril-treated cells: % of perinuclear lysosomes: 44 ± 1%, and peripheral lysosomes: 56 ± 1%. Mean ± SEM, n = 5 (40 cells per condition). ns = not significant, ****P < 0.0001 by 1-way ANOVA followed by Tukey multiple comparison tests. (C) Graph representing the distribution of LysoTracker DR+ and Magic Red CathB+ lysosomes colocalizing with the α-syn fibrils in perinuclear (purple dots) and peripheral region (black dots). % of LysoTracker DR+ lysosomes colocalizing with α-syn fibrils in perinuclear region: 54 ± 2%, and in peripheral region: 46 ± 2%. % of Magic Red CathB+ lysosomes colocalizing with α-syn fibrils in perinuclear region: 56 ± 1%, and in peripheral region: 44 ± 1%. Mean ± SEM, n = 4 (40 cells per condition). ns = not significant by 1-way ANOVA followed by Tukey multiple comparison tests. (D) Quantity of secreted CathB (ELISA) in the media of control (70 ± 1 ng/mL) and α-syn fibril-treated CAD cells (75 ± 7 ng/mL). Mean ± SEM, n = 3. ns = not significant by Mann–Whitney U test. (E) Representative confocal images of control and Alexa 568–tagged α-syn fibril-treated CAD cells for 18 hours, immuno-labeled for LAMP1-Alexa 488 antibody in non-permeabilized conditions. Scale bar: 10 μm. Average integrated density of LAMP1 immunofluorescence at the cell surface in control (9 × 104 ± 2 × 104) and in α-syn fibril-treated cells (9 × 104 ± 3 × 104) is presented. Mean ± SEM, n = 3 (20 cells per condition). ns = not significant by paired t test. Scale bar: 10 μm. (F) Representative confocal images of donor and acceptor cells after 24 hours of coculture. Donor cells were transfected with LAMP1-GFP and treated with Alexa 568–tagged α-syn fibrils or not (referred to as “α-syn coculture” and “control coculture,” respectively). Acceptor cells were transfected with H2B-mCherry. Scale bar: 20 μm. (G) % of acceptor cells that received LAMP1+ puncta (lysosomes) from donor cells in control coculture (18 ± 2%), in α-syn coculture (29 ± 3%), in control secretion test (9 ± 2%), and in α-syn secretion test (7 ± 1%) (left graph). Mean ± SEM, n = 4 (150 acceptor cells per condition). ns = not significant, ***P = 0.0004 by 1-way ANOVA followed by Tukey multiple comparison tests. The average number of LAMP1-GFP+ puncta detected per acceptor cell in control coculture (2 ± 0.2), in α-syn coculture (2 ± 0.2), in control secretion (1 ± 0.1), and in α-syn secretion (1 ± 0.1) is presented (right graph). Mean ± SEM, n = 4 (150 acceptor cells per condition). ns = not significant, ***P = 0.0004 by Kruskal–Wallis nonparametric ANOVA test followed by Dunn multiple comparison tests. (H) % of α-syn fibril puncta colocalizing with LAMP1-GFP+ puncta (51 ± 6%) and % of LAMP1-GFP+ puncta colocalizing with α-syn fibrils puncta (51 ± 6%) is presented. Mean ± SEM, n = 4 (20 acceptor cells that received both α-syn fibrils and LAMP1-GFP puncta were analyzed). The data underlying this figure may be found in S1 Data. α-syn, α-synuclein; AU, arbitrary unit; CAD, Cath.a-differentiated; CathB, Cathepsin B; LAMP, lysosome-associated membrane protein; LysoTracker DR, LysoTracker Deep Red.
Fig 5 α-Syn–loaded lysosomes localize to the cell periphery, are less functional, and are preferentially transferred to neighboring cells. (A) Representative confocal images of control and Alexa 568–tagged α-syn fibril-treated CAD cells (18 hours) labeled for LAMP1-Alexa 488 antibody, HCS CellMask Blue, and DAPI. White arrows indicate the perinuclear lysosome clusters in control cells; green, red, and yellow arrows indicate peripheral lysosomes, α-syn fibrils, and lysosomes colocalizing with α-syn fibrils, respectively. Scale bar: 10 μm. (B) % of LAMP1+ lysosomes in perinuclear (purple dots) and peripheral regions (black dots) of the control cells and cells challenged with α-syn fibrils is presented. In control cells: % of perinuclear lysosomes: 57 ± 1%, and peripheral lysosomes: 43 ± 1%; in α-syn fibril-treated cells: % of perinuclear lysosomes: 44 ± 1%, and peripheral lysosomes: 56 ± 1%. Mean ± SEM, n = 5 (40 cells per condition). ns = not significant, ****P < 0.0001 by 1-way ANOVA followed by Tukey multiple comparison tests. (C) Graph representing the distribution of LysoTracker DR+ and Magic Red CathB+ lysosomes colocalizing with the α-syn fibrils in perinuclear (purple dots) and peripheral region (black dots). % of LysoTracker DR+ lysosomes colocalizing with α-syn fibrils in perinuclear region: 54 ± 2%, and in peripheral region: 46 ± 2%. % of Magic Red CathB+ lysosomes colocalizing with α-syn fibrils in perinuclear region: 56 ± 1%, and in peripheral region: 44 ± 1%. Mean ± SEM, n = 4 (40 cells per condition). ns = not significant by 1-way ANOVA followed by Tukey multiple comparison tests. (D) Quantity of secreted CathB (ELISA) in the media of control (70 ± 1 ng/mL) and α-syn fibril-treated CAD cells (75 ± 7 ng/mL). Mean ± SEM, n = 3. ns = not significant by Mann–Whitney U test. (E) Representative confocal images of control and Alexa 568–tagged α-syn fibril-treated CAD cells for 18 hours, immuno-labeled for LAMP1-Alexa 488 antibody in non-permeabilized conditions. Scale bar: 10 μm. Average integrated density of LAMP1 immunofluorescence at the cell surface in control (9 × 104 ± 2 × 104) and in α-syn fibril-treated cells (9 × 104 ± 3 × 104) is presented. Mean ± SEM, n = 3 (20 cells per condition). ns = not significant by paired t test. Scale bar: 10 μm. (F) Representative confocal images of donor and acceptor cells after 24 hours of coculture. Donor cells were transfected with LAMP1-GFP and treated with Alexa 568–tagged α-syn fibrils or not (referred to as “α-syn coculture” and “control coculture,” respectively). Acceptor cells were transfected with H2B-mCherry. Scale bar: 20 μm. (G) % of acceptor cells that received LAMP1+ puncta (lysosomes) from donor cells in control coculture (18 ± 2%), in α-syn coculture (29 ± 3%), in control secretion test (9 ± 2%), and in α-syn secretion test (7 ± 1%) (left graph). Mean ± SEM, n = 4 (150 acceptor cells per condition). ns = not significant, ***P = 0.0004 by 1-way ANOVA followed by Tukey multiple comparison tests. The average number of LAMP1-GFP+ puncta detected per acceptor cell in control coculture (2 ± 0.2), in α-syn coculture (2 ± 0.2), in control secretion (1 ± 0.1), and in α-syn secretion (1 ± 0.1) is presented (right graph). Mean ± SEM, n = 4 (150 acceptor cells per condition). ns = not significant, ***P = 0.0004 by Kruskal–Wallis nonparametric ANOVA test followed by Dunn multiple comparison tests. (H) % of α-syn fibril puncta colocalizing with LAMP1-GFP+ puncta (51 ± 6%) and % of LAMP1-GFP+ puncta colocalizing with α-syn fibrils puncta (51 ± 6%) is presented. Mean ± SEM, n = 4 (20 acceptor cells that received both α-syn fibrils and LAMP1-GFP puncta were analyzed). The data underlying this figure may be found in S1 Data. α-syn, α-synuclein; AU, arbitrary unit; CAD, Cath.a-differentiated; CathB, Cathepsin B; LAMP, lysosome-associated membrane protein; LysoTracker DR, LysoTracker Deep Red.CC0 · PubMed Central
Fig 6 The role of TFEB in lysosome redistribution upon α-syn loading. (A) % of cells overexpressing TFEB-WT-GFP having nuclear TFEB in control CAD cells (18 ± 4%) and α-syn fibril-treated CAD cells for 18 hours (57 ± 6%). Mean ± SEM, n = 3 (50 cells per condition). ****P < 0.0001 by unpaired t test. (B) % of LAMP1+ lysosome distribution in perinuclear (purple dots) and peripheral regions (black dots) of cells overexpressing CMV-GFP (control), TFEB-WT-GFP, or TFEB-mut-GFP. In control CMV-GFP cells: % of perinuclear lysosomes: 48 ± 1%, and peripheral lysosomes: 52 ± 1%; in TFEB-WT-GFP cells: % of perinuclear lysosomes: 46 ± 2%, and peripheral lysosomes: 54 ± 2%; in TFEB-mut-GFP cells: % of perinuclear lysosomes: 41 ± 1%, and peripheral lysosomes: 59 ± 1%. Mean ± SEM, n = 3 (30 cells per condition). ***P < 0.001 by 1-way ANOVA followed by Tukey multiple comparison tests. (C) Western blot prepared from cell extracts collected from control, scrambled siRNA (sicontrol)-, and siTFEB-pretreated CAD cells for 60 hours, showing TFEB and GAPDH (loading control) expression. (D) Graph representing the distribution of lysosomes containing α-syn fibrils in perinuclear (purple dots) and peripheral region (black dots) of α-syn fibril-treated sicontrol and siTFEB cells. % of lysosomes containing α-syn fibrils of sicontrol cells in perinuclear region: 49 ± 1%, and in peripheral region: 52 ± 1%. % of lysosomes containing α-syn fibrils of siTFEB cells in perinuclear region: 51 ± 1%, and in peripheral region: 49 ± 1%. Mean ± SEM, n = 4 (30 cells per condition). ns = not significant, *P = 0.0288 by 1-way ANOVA followed by Tukey multiple comparison tests. The data underlying this figure may be found in S1 Data. α-syn, α-synuclein; CAD, Cath.a-differentiated; LAMP, lysosome-associated membrane protein; siRNA, small interfering RNA; siTFEB, siRNA targeting TFEB; sicontrol, scrambled siRNA; TFEB, transcription factor EB; WT, wild-type.
Fig 6 The role of TFEB in lysosome redistribution upon α-syn loading. (A) % of cells overexpressing TFEB-WT-GFP having nuclear TFEB in control CAD cells (18 ± 4%) and α-syn fibril-treated CAD cells for 18 hours (57 ± 6%). Mean ± SEM, n = 3 (50 cells per condition). ****P < 0.0001 by unpaired t test. (B) % of LAMP1+ lysosome distribution in perinuclear (purple dots) and peripheral regions (black dots) of cells overexpressing CMV-GFP (control), TFEB-WT-GFP, or TFEB-mut-GFP. In control CMV-GFP cells: % of perinuclear lysosomes: 48 ± 1%, and peripheral lysosomes: 52 ± 1%; in TFEB-WT-GFP cells: % of perinuclear lysosomes: 46 ± 2%, and peripheral lysosomes: 54 ± 2%; in TFEB-mut-GFP cells: % of perinuclear lysosomes: 41 ± 1%, and peripheral lysosomes: 59 ± 1%. Mean ± SEM, n = 3 (30 cells per condition). ***P < 0.001 by 1-way ANOVA followed by Tukey multiple comparison tests. (C) Western blot prepared from cell extracts collected from control, scrambled siRNA (sicontrol)-, and siTFEB-pretreated CAD cells for 60 hours, showing TFEB and GAPDH (loading control) expression. (D) Graph representing the distribution of lysosomes containing α-syn fibrils in perinuclear (purple dots) and peripheral region (black dots) of α-syn fibril-treated sicontrol and siTFEB cells. % of lysosomes containing α-syn fibrils of sicontrol cells in perinuclear region: 49 ± 1%, and in peripheral region: 52 ± 1%. % of lysosomes containing α-syn fibrils of siTFEB cells in perinuclear region: 51 ± 1%, and in peripheral region: 49 ± 1%. Mean ± SEM, n = 4 (30 cells per condition). ns = not significant, *P = 0.0288 by 1-way ANOVA followed by Tukey multiple comparison tests. The data underlying this figure may be found in S1 Data. α-syn, α-synuclein; CAD, Cath.a-differentiated; LAMP, lysosome-associated membrane protein; siRNA, small interfering RNA; siTFEB, siRNA targeting TFEB; sicontrol, scrambled siRNA; TFEB, transcription factor EB; WT, wild-type.CC0 · PubMed Central
Fig 7 Lysosome positioning affects the efficiency of α-syn fibrils’ transfer. (A) Representative confocal images of donor and acceptor cells after 24 hours of coculture. Donor cells were either loaded with Alexa 568–tagged α-syn fibrils only (control coculture) or transfected with Arl8b-GFP prior to be treated with α-syn fibrils (Arl8b-GFP coculture). Acceptor cells were transfected with H2B-GFP. Cocultures were labeled with HCS CellMask Blue and DAPI. Arrows indicate the α-syn fibrils received by acceptor cells, and asterisks indicate the cells having α-syn fibrils in each coculture condition. Scale bar: 10 μm. (B) % of acceptor cells received α-syn fibrils in control coculture (49 ± 4%), in Arl8b-GFP coculture (65 ± 4%), in control secretion (8 ± 2%), and in Arl8b-GFP secretion (10 ± 2%) (left graph). Mean ± SEM, n = 3 (90 acceptor cells per condition). ns = not significant, **P = 0.0038 by Kruskal–Wallis nonparametric ANOVA test followed by Dunn multiple comparison tests. Average number of α-syn fibrils puncta in control coculture (3 ± 0.4), in Arl8b-GFP coculture (3.4 ± 0.4), in control secretion (1.3 ± 0.4), and in Arl8b-GFP secretion (2 ± 0.3) (right graph). Mean ± SEM, n = 3 (90 acceptor cells per condition). ns = not significant, by 1-way ANOVA followed by Tukey multiple comparison tests. (C) Western blot prepared from cell extracts collected from control, scrambled siRNA (sicontrol)-, and siArl8b-pretreated CAD cells for 60 hours, showing Arl8b and α-tubulin (loading control) expression. Integrated density of Arl8b protein expression levels normalized to α-tubulin in control (0.80 ± 0.03), sicontrol- (0.82 ± 0.02), and siArl8b-pretreated cells (0.19 ± 0.09) are presented in AU. Mean ± SEM, n = 3. ns = not significant, ***P = 0.0004 by 1-way ANOVA followed by Tukey multiple comparison tests. (D) Representative confocal images of donor and acceptor cells after 24 hours of coculture. Donor CAD cells were pretreated with sicontrol or siArl8b for 60 hours or left untreated prior to be challenged with Alexa 568–tagged α-syn fibrils (referred to as control, sicontrol, and siArl8b cocultures, respectively). Acceptor cells were transfected with H2B-GFP. Cocultures were labeled with HCS CellMask Blue and DAPI. Arrows indicate the α-syn fibrils received by acceptor cells, and asterisks indicate the cells having α-syn fibrils in each coculture condition. Scale bar: 10 μm. (E) % of acceptor cells that received α-syn fibrils in control coculture (55 ± 4%), sicontrol coculture (60 ± 3%), siArl8b coculture (28 ± 3%), control secretion (6 ± 1%), sicontrol secretion (9 ± 1%), and siArl8b secretion (6 ± 1%) (left graph). Mean ± SEM, n = 4 (80 acceptor cells per condition). ns = not significant, ****P < 0.0001 by 1-way ANOVA followed by Tukey multiple comparison tests. Average number of α-syn puncta per acceptor cell in control coculture (2 ± 0.2), sicontrol coculture (2 ± 0.1), siArl8b coculture (2 ± 0.3), control secretion (1 ± 0.2), sicontrol secretion (2 ± 0.2), and siArl8b secretion (2 ± 0.3) (right graph). Mean ± SEM, n = 4 (80 acceptor cells per condition). ns = not significant by Kruskal–Wallis nonparametric ANOVA test followed by Dunn multiple comparison tests. (F) Control, Arl8b-GFP transfected, and sicontrol- or siArl8b-pretreated CAD cells for 60 hours were challenged or not with α-syn fibrils (18 hours) and labeled with WGA for TNT counting experiments. % of TNT-connected cells in control (45 ± 3%), Arl8b-GFP (46 ± 2%), control-α-syn (60 ± 5%), and Arl8b-GFP-α-syn (64 ± 5%) conditions. Mean ± SEM, n = 4 (115 cells per condition). ns = not significant (left graph). % of TNT-connected cells in control (44 ± 4%), sicontrol (45 ± 4%), siArl8b (43 ± 4%), control-α-syn (62 ± 4%), sicontrol-α-syn (62 ± 5%), and siArl8b-α-syn (66 ± 3%) is presented (right graph). Mean ± SEM, n = 3 (90 cells per condition). ns = not significant, *P < 0.05, **P < 0.01 by 1-way ANOVA followed by Tukey multiple comparison tests. The data underlying this figure may be found in S1 Data. α-syn, α-synuclein; AU, arbitrary unit; CAD, Cath.a-differentiated; siRNA, small interfering RNA; siArl8b, siRNA targeting Arl8b; sicontrol, scrambled siRNA; TNT, tunneling nanotube; WGA, wheat germ agglutinin.
Fig 7 Lysosome positioning affects the efficiency of α-syn fibrils’ transfer. (A) Representative confocal images of donor and acceptor cells after 24 hours of coculture. Donor cells were either loaded with Alexa 568–tagged α-syn fibrils only (control coculture) or transfected with Arl8b-GFP prior to be treated with α-syn fibrils (Arl8b-GFP coculture). Acceptor cells were transfected with H2B-GFP. Cocultures were labeled with HCS CellMask Blue and DAPI. Arrows indicate the α-syn fibrils received by acceptor cells, and asterisks indicate the cells having α-syn fibrils in each coculture condition. Scale bar: 10 μm. (B) % of acceptor cells received α-syn fibrils in control coculture (49 ± 4%), in Arl8b-GFP coculture (65 ± 4%), in control secretion (8 ± 2%), and in Arl8b-GFP secretion (10 ± 2%) (left graph). Mean ± SEM, n = 3 (90 acceptor cells per condition). ns = not significant, **P = 0.0038 by Kruskal–Wallis nonparametric ANOVA test followed by Dunn multiple comparison tests. Average number of α-syn fibrils puncta in control coculture (3 ± 0.4), in Arl8b-GFP coculture (3.4 ± 0.4), in control secretion (1.3 ± 0.4), and in Arl8b-GFP secretion (2 ± 0.3) (right graph). Mean ± SEM, n = 3 (90 acceptor cells per condition). ns = not significant, by 1-way ANOVA followed by Tukey multiple comparison tests. (C) Western blot prepared from cell extracts collected from control, scrambled siRNA (sicontrol)-, and siArl8b-pretreated CAD cells for 60 hours, showing Arl8b and α-tubulin (loading control) expression. Integrated density of Arl8b protein expression levels normalized to α-tubulin in control (0.80 ± 0.03), sicontrol- (0.82 ± 0.02), and siArl8b-pretreated cells (0.19 ± 0.09) are presented in AU. Mean ± SEM, n = 3. ns = not significant, ***P = 0.0004 by 1-way ANOVA followed by Tukey multiple comparison tests. (D) Representative confocal images of donor and acceptor cells after 24 hours of coculture. Donor CAD cells were pretreated with sicontrol or siArl8b for 60 hours or left untreated prior to be challenged with Alexa 568–tagged α-syn fibrils (referred to as control, sicontrol, and siArl8b cocultures, respectively). Acceptor cells were transfected with H2B-GFP. Cocultures were labeled with HCS CellMask Blue and DAPI. Arrows indicate the α-syn fibrils received by acceptor cells, and asterisks indicate the cells having α-syn fibrils in each coculture condition. Scale bar: 10 μm. (E) % of acceptor cells that received α-syn fibrils in control coculture (55 ± 4%), sicontrol coculture (60 ± 3%), siArl8b coculture (28 ± 3%), control secretion (6 ± 1%), sicontrol secretion (9 ± 1%), and siArl8b secretion (6 ± 1%) (left graph). Mean ± SEM, n = 4 (80 acceptor cells per condition). ns = not significant, ****P < 0.0001 by 1-way ANOVA followed by Tukey multiple comparison tests. Average number of α-syn puncta per acceptor cell in control coculture (2 ± 0.2), sicontrol coculture (2 ± 0.1), siArl8b coculture (2 ± 0.3), control secretion (1 ± 0.2), sicontrol secretion (2 ± 0.2), and siArl8b secretion (2 ± 0.3) (right graph). Mean ± SEM, n = 4 (80 acceptor cells per condition). ns = not significant by Kruskal–Wallis nonparametric ANOVA test followed by Dunn multiple comparison tests. (F) Control, Arl8b-GFP transfected, and sicontrol- or siArl8b-pretreated CAD cells for 60 hours were challenged or not with α-syn fibrils (18 hours) and labeled with WGA for TNT counting experiments. % of TNT-connected cells in control (45 ± 3%), Arl8b-GFP (46 ± 2%), control-α-syn (60 ± 5%), and Arl8b-GFP-α-syn (64 ± 5%) conditions. Mean ± SEM, n = 4 (115 cells per condition). ns = not significant (left graph). % of TNT-connected cells in control (44 ± 4%), sicontrol (45 ± 4%), siArl8b (43 ± 4%), control-α-syn (62 ± 4%), sicontrol-α-syn (62 ± 5%), and siArl8b-α-syn (66 ± 3%) is presented (right graph). Mean ± SEM, n = 3 (90 cells per condition). ns = not significant, *P < 0.05, **P < 0.01 by 1-way ANOVA followed by Tukey multiple comparison tests. The data underlying this figure may be found in S1 Data. α-syn, α-synuclein; AU, arbitrary unit; CAD, Cath.a-differentiated; siRNA, small interfering RNA; siArl8b, siRNA targeting Arl8b; sicontrol, scrambled siRNA; TNT, tunneling nanotube; WGA, wheat germ agglutinin.CC0 · PubMed Central
Fig 8 α-Syn fibrils induce LMP upon arrival in the acceptor cells. (A) Representative confocal images of donor and acceptor cells after 24 hours of coculture. Donor cells were transfected with H2B-mCherry (control coculture) or treated with Alexa 568–tagged α-syn fibrils (α-syn coculture). Acceptor cells were transfected with Gal3-GFP. Cocultures were labeled with HCS CellMask Blue. Red arrows indicate the α-syn fibrils received by acceptor cells, white arrows indicate the Gal3-GFP puncta formation (LMP) in the acceptor cells that received α-syn fibrils. Scale bar: 10 μm. (B) % of acceptor cells under LMP in control (6 ± 2%) and α-syn (33 ± 5%) cocultures (upper graph). Average number of Gal3-GFP puncta formation in acceptor cells under LMP in control (8 ± 1) and α-syn (14 ± 1) cocultures (lower graph). Mean ± SEM, n = 5 (50 acceptor cells per condition). *P = 0.04, ****P < 0.0001 by Mann–Whitney U test. (C) SR image of a coculture where donor cells were treated with α-syn fibrils for 18 hours and acceptor cells were transfected with Gal3-GFP, labeled for LAMP1-Alexa 647 antibody (pseudo colored in gray). A selected region where Gal3-GFP puncta were observed (indicated by a white square in the acceptor cell of the coculture image) was further magnified to observe one lysosome (indicated by the small white square) having α-syn fibrils puncta and recruited Gal3-GFP. Image was acquired with a spinning disk microscope with SR module. Scale bar: 10 μm (for the inset: 0.2 μm). (D) SR image of an acceptor cell demonstrating Gal3-GFP puncta recruited at the lysosomal membrane where α-syn fibrils were detected in close proximity. Selected lysosome is indicated by a white square. Image was acquired by SR SIM (Zeiss, LSM 780-Elyra PS.1). Scale bar: 5 μm (for the inset: 0.5 μm). In C, the signal was boosted to make the selected lysosome visible; in D, the acceptor cell was presented with HCS CellMask Blue labeling as this cell was poorly transfected but accumulation of Gal3-GFP puncta was clearly detectable. The data underlying this figure may be found in S1 Data. α-syn, α-synuclein; Gal3, Galectin-3; LAMP, lysosome-associated membrane protein; LMP, lysosomal membrane permeabilization; SIM, structured illumination microscopy; SR, super-resolution.
Fig 8 α-Syn fibrils induce LMP upon arrival in the acceptor cells. (A) Representative confocal images of donor and acceptor cells after 24 hours of coculture. Donor cells were transfected with H2B-mCherry (control coculture) or treated with Alexa 568–tagged α-syn fibrils (α-syn coculture). Acceptor cells were transfected with Gal3-GFP. Cocultures were labeled with HCS CellMask Blue. Red arrows indicate the α-syn fibrils received by acceptor cells, white arrows indicate the Gal3-GFP puncta formation (LMP) in the acceptor cells that received α-syn fibrils. Scale bar: 10 μm. (B) % of acceptor cells under LMP in control (6 ± 2%) and α-syn (33 ± 5%) cocultures (upper graph). Average number of Gal3-GFP puncta formation in acceptor cells under LMP in control (8 ± 1) and α-syn (14 ± 1) cocultures (lower graph). Mean ± SEM, n = 5 (50 acceptor cells per condition). *P = 0.04, ****P < 0.0001 by Mann–Whitney U test. (C) SR image of a coculture where donor cells were treated with α-syn fibrils for 18 hours and acceptor cells were transfected with Gal3-GFP, labeled for LAMP1-Alexa 647 antibody (pseudo colored in gray). A selected region where Gal3-GFP puncta were observed (indicated by a white square in the acceptor cell of the coculture image) was further magnified to observe one lysosome (indicated by the small white square) having α-syn fibrils puncta and recruited Gal3-GFP. Image was acquired with a spinning disk microscope with SR module. Scale bar: 10 μm (for the inset: 0.2 μm). (D) SR image of an acceptor cell demonstrating Gal3-GFP puncta recruited at the lysosomal membrane where α-syn fibrils were detected in close proximity. Selected lysosome is indicated by a white square. Image was acquired by SR SIM (Zeiss, LSM 780-Elyra PS.1). Scale bar: 5 μm (for the inset: 0.5 μm). In C, the signal was boosted to make the selected lysosome visible; in D, the acceptor cell was presented with HCS CellMask Blue labeling as this cell was poorly transfected but accumulation of Gal3-GFP puncta was clearly detectable. The data underlying this figure may be found in S1 Data. α-syn, α-synuclein; Gal3, Galectin-3; LAMP, lysosome-associated membrane protein; LMP, lysosomal membrane permeabilization; SIM, structured illumination microscopy; SR, super-resolution.CC0 · PubMed Central
Fig 9 α-syn fibrils induce seeding after their transfer into acceptor cells, and this event is frequently associated with lysosomes. (A) Representative confocal images of donor and acceptor cells after 24 hours of coculture. Donor cells were transfected with H2B-mCherry (control coculture) or treated with Alexa 568–tagged α-syn fibrils for 18 hours (α-syn coculture). Acceptor cells were transfected with α-syn-GFP. Inset of acceptor cells (indicated by white squares) is presented at the right top corner of acceptor cells’ panel. White arrows indicate α-syn-GFP aggregate formation, and red arrows indicate α-syn fibrils received by acceptor cells in α-syn coculture. Scale bar: 10 μm (for the inset: 5 μm). (B) % of acceptor cells that formed α-syn-GFP aggregates in control (10 ± 4%) and in α-syn (27 ± 4%) cocultures (left graph). Average number of α-syn-GFP puncta detected in acceptor cells in control (2 ± 0.2) and in α-syn (7 ± 1) cocultures is presented (right graph). Mean ± SEM, n = 3 (150 acceptor cells per condition). *P = 0.01 and **P = 0.003 for % of aggregates and average number of aggregates in control versus α-syn cocultures, respectively, by Mann–Whitney U test. (C) SR image showing a lysosome containing α-syn fibrils puncta colocalizing with α-syn-GFP+ aggregate at the lysosomal membrane. (D) SR image showing a lysosome containing α-syn fibrils where α-syn-GFP+ aggregate is located mostly in a restricted portion of the lysosomal membrane. (E) SR image showing a lysosome having α-syn-GFP+ aggregate where α-syn fibrils puncta were found to be in close proximity of the lysosomes. (F) SR image showing a lysosome where both α-syn fibrils and α-syn-GFP aggregates are located to the lumen of the lysosome and partially colocalizing. (G) Object-based 3D analysis (Imaris software) of colocalization between α-syn-GFP and LAMP1+ lysosomes (60 ± 7%). Mean ± SEM, n = 2 (15 SR images, approximately 3,000 lysosomes were analyzed). Insets of images in C and D (acquired with spinning disk microscope with SR module) and E and F (acquired with SR SIM, Zeiss, LSM 780-Elyra PS.1) from 4 selected regions (white squares) and from different acceptor cells transfected with α-syn-GFP and that received α-syn fibrils, labeled for LAMP1 Alexa 647 antibody (pseudo colored in gray). Scale bars: 10 μm (for the insets: 1 μm). The data underlying this figure may be found in S1 Data. α-syn, α-synuclein; LAMP, lysosome-associated membrane protein; SIM, structured illumination microscopy; SR, super-resolution.
Fig 9 α-syn fibrils induce seeding after their transfer into acceptor cells, and this event is frequently associated with lysosomes. (A) Representative confocal images of donor and acceptor cells after 24 hours of coculture. Donor cells were transfected with H2B-mCherry (control coculture) or treated with Alexa 568–tagged α-syn fibrils for 18 hours (α-syn coculture). Acceptor cells were transfected with α-syn-GFP. Inset of acceptor cells (indicated by white squares) is presented at the right top corner of acceptor cells’ panel. White arrows indicate α-syn-GFP aggregate formation, and red arrows indicate α-syn fibrils received by acceptor cells in α-syn coculture. Scale bar: 10 μm (for the inset: 5 μm). (B) % of acceptor cells that formed α-syn-GFP aggregates in control (10 ± 4%) and in α-syn (27 ± 4%) cocultures (left graph). Average number of α-syn-GFP puncta detected in acceptor cells in control (2 ± 0.2) and in α-syn (7 ± 1) cocultures is presented (right graph). Mean ± SEM, n = 3 (150 acceptor cells per condition). *P = 0.01 and **P = 0.003 for % of aggregates and average number of aggregates in control versus α-syn cocultures, respectively, by Mann–Whitney U test. (C) SR image showing a lysosome containing α-syn fibrils puncta colocalizing with α-syn-GFP+ aggregate at the lysosomal membrane. (D) SR image showing a lysosome containing α-syn fibrils where α-syn-GFP+ aggregate is located mostly in a restricted portion of the lysosomal membrane. (E) SR image showing a lysosome having α-syn-GFP+ aggregate where α-syn fibrils puncta were found to be in close proximity of the lysosomes. (F) SR image showing a lysosome where both α-syn fibrils and α-syn-GFP aggregates are located to the lumen of the lysosome and partially colocalizing. (G) Object-based 3D analysis (Imaris software) of colocalization between α-syn-GFP and LAMP1+ lysosomes (60 ± 7%). Mean ± SEM, n = 2 (15 SR images, approximately 3,000 lysosomes were analyzed). Insets of images in C and D (acquired with spinning disk microscope with SR module) and E and F (acquired with SR SIM, Zeiss, LSM 780-Elyra PS.1) from 4 selected regions (white squares) and from different acceptor cells transfected with α-syn-GFP and that received α-syn fibrils, labeled for LAMP1 Alexa 647 antibody (pseudo colored in gray). Scale bars: 10 μm (for the insets: 1 μm). The data underlying this figure may be found in S1 Data. α-syn, α-synuclein; LAMP, lysosome-associated membrane protein; SIM, structured illumination microscopy; SR, super-resolution.CC0 · PubMed Central
Fig 10 Intercellular lysosome transfer is reciprocal. (A) Representative confocal image of CAD-HeLa coculture where donor mouse CAD cells were treated with Alexa 568–tagged α-syn fibrils (18 hours) and cocultured with acceptor human HeLa stable Gal3-Turquoise cells for 24 hours, labeled for anti-LAMP1 mouse antibody and DAPI. In acceptor HeLa Gal3-Turquoise cells, arrows indicate donors’ lysosomes containing (yellow) or not (white) α-syn fibrils. Inset represents a selected region (white square) of one acceptor cell containing donors’ lysosomes. Scale bar: 10 μm (for the inset: 2 μm). (B) % of acceptor HeLa cells that received lysosomes from donor CAD cells in control (32 ± 5%) and in α-syn (52 ± 4%) cocultures (left graph). **P = 0.006 by 2-tailed t test. Average number of lysosomes transferred from donor to acceptor cells in control (3 ± 0.3) and in α-syn (3 ± 0.3) cocultures (right graph). Mean ± SEM. ns = not significant by Mann–Whitney U test. (C) Representative confocal image of CAD-HeLa coculture where Gal3-GFP transfected donor CAD cells were treated with Alexa 568–tagged α-syn fibrils for 18 hours and cocultured with HeLa Gal3-Turquoise for 24 hours, labeled with DAPI. In acceptor HeLa Gal3-Turquoise cells, red arrows indicate α-syn fibrils, and green arrows indicate Gal3-GFP puncta (lysosomes under LMP received from donor cells). Scale bar: 10 μm. (D) % of acceptor HeLa cells that received Gal3-GFP puncta from donor cells in control (4 ± 1%) and in α-syn (13 ± 2%) cocultures (left graph); average number of Gal3-GFP puncta per acceptor HeLa cell in control (2 ± 0.3) and in α-syn (2 ± 0.2) cocultures (right graph). Mean ± SEM. ns = not significant, *P = 0.04 by Mann–Whitney U test. (E) Acceptor HeLa Gal3-Turquoise cell that received a donor’s lysosome containing α-syn fibrils and under LMP. Colocalization between LAMP1 (labeled with anti-LAMP1 mouse antibody), α-syn fibrils, and Gal3-GFP is presented in the inset of the selected area (white square). Scale bar: 10 μm (for the inset: 1 μm). (F) Representative confocal image of LMP in HeLa Gal3-Turquoise (pseudo colored in yellow) acceptor cell in CAD-HeLa coculture. In acceptor HeLa Gal3-Turquoise cells, red arrows indicate the α-syn fibrils, and turquoise arrows indicate the Gal3Turquoise puncta. Scale bar: 10 μm. (G) % of acceptor HeLa cells under LMP in control (3 ± 1%) and in α-syn (18 ± 3%) cocultures is presented (left graph); average number of Gal3-Turquoise puncta per acceptor cell under LMP in control (9 ± 1) and in α-syn (10 ± 1) cocultures is presented (right graph). Mean ± SEM. ns = not significant, *P = 0.03 by Mann–Whitney U test. (H) Representative confocal image of CAD-HeLa coculture where donor CAD cells were treated with Alexa 568–tagged α-syn fibrils for 18 hours and cocultured with HeLa Gal3-Turquoise for 24 hours, labeled for anti-LAMP1 human antibody and DAPI. In donor CAD cells, white arrows indicate acceptors’ lysosomes. Inset of a selected region of a donor CAD cell (white square) showing acceptors’ lysosomes in higher magnification. Scale bar: 10 μm (for the inset: 5 μm). (I) % of acceptors’ lysosomes transferred from acceptor to donor cells in control (14 ± 4%) and in α-syn (34 ± 5%) cocultures (left graph). **P = 0.002 by 2-tailed t test. Average number of acceptors’ lysosomes per donor cell in control (2 ± 0.3) and in α-syn (2 ± 0.1) cocultures (right graph). Mean ± SEM. ns = not significant by Mann–Whitney U test. In CAD-HeLa coculture model, data were collected from 7 independent experiments in which 4 and 3 of them were labeled with anti-LAMP1 mouse and human antibodies, respectively. According to the experiment, in average, 100 acceptor or donor cells were analyzed for each condition per experiment. The data underlying this figure may be found in S1 Data. α-syn, α-synuclein; CAD, Cath.a-differentiated; Gal3, Galectin-3; LAMP, lysosome-associated membrane protein; LMP, lysosomal membrane permeabilization.
Fig 10 Intercellular lysosome transfer is reciprocal. (A) Representative confocal image of CAD-HeLa coculture where donor mouse CAD cells were treated with Alexa 568–tagged α-syn fibrils (18 hours) and cocultured with acceptor human HeLa stable Gal3-Turquoise cells for 24 hours, labeled for anti-LAMP1 mouse antibody and DAPI. In acceptor HeLa Gal3-Turquoise cells, arrows indicate donors’ lysosomes containing (yellow) or not (white) α-syn fibrils. Inset represents a selected region (white square) of one acceptor cell containing donors’ lysosomes. Scale bar: 10 μm (for the inset: 2 μm). (B) % of acceptor HeLa cells that received lysosomes from donor CAD cells in control (32 ± 5%) and in α-syn (52 ± 4%) cocultures (left graph). **P = 0.006 by 2-tailed t test. Average number of lysosomes transferred from donor to acceptor cells in control (3 ± 0.3) and in α-syn (3 ± 0.3) cocultures (right graph). Mean ± SEM. ns = not significant by Mann–Whitney U test. (C) Representative confocal image of CAD-HeLa coculture where Gal3-GFP transfected donor CAD cells were treated with Alexa 568–tagged α-syn fibrils for 18 hours and cocultured with HeLa Gal3-Turquoise for 24 hours, labeled with DAPI. In acceptor HeLa Gal3-Turquoise cells, red arrows indicate α-syn fibrils, and green arrows indicate Gal3-GFP puncta (lysosomes under LMP received from donor cells). Scale bar: 10 μm. (D) % of acceptor HeLa cells that received Gal3-GFP puncta from donor cells in control (4 ± 1%) and in α-syn (13 ± 2%) cocultures (left graph); average number of Gal3-GFP puncta per acceptor HeLa cell in control (2 ± 0.3) and in α-syn (2 ± 0.2) cocultures (right graph). Mean ± SEM. ns = not significant, *P = 0.04 by Mann–Whitney U test. (E) Acceptor HeLa Gal3-Turquoise cell that received a donor’s lysosome containing α-syn fibrils and under LMP. Colocalization between LAMP1 (labeled with anti-LAMP1 mouse antibody), α-syn fibrils, and Gal3-GFP is presented in the inset of the selected area (white square). Scale bar: 10 μm (for the inset: 1 μm). (F) Representative confocal image of LMP in HeLa Gal3-Turquoise (pseudo colored in yellow) acceptor cell in CAD-HeLa coculture. In acceptor HeLa Gal3-Turquoise cells, red arrows indicate the α-syn fibrils, and turquoise arrows indicate the Gal3Turquoise puncta. Scale bar: 10 μm. (G) % of acceptor HeLa cells under LMP in control (3 ± 1%) and in α-syn (18 ± 3%) cocultures is presented (left graph); average number of Gal3-Turquoise puncta per acceptor cell under LMP in control (9 ± 1) and in α-syn (10 ± 1) cocultures is presented (right graph). Mean ± SEM. ns = not significant, *P = 0.03 by Mann–Whitney U test. (H) Representative confocal image of CAD-HeLa coculture where donor CAD cells were treated with Alexa 568–tagged α-syn fibrils for 18 hours and cocultured with HeLa Gal3-Turquoise for 24 hours, labeled for anti-LAMP1 human antibody and DAPI. In donor CAD cells, white arrows indicate acceptors’ lysosomes. Inset of a selected region of a donor CAD cell (white square) showing acceptors’ lysosomes in higher magnification. Scale bar: 10 μm (for the inset: 5 μm). (I) % of acceptors’ lysosomes transferred from acceptor to donor cells in control (14 ± 4%) and in α-syn (34 ± 5%) cocultures (left graph). **P = 0.002 by 2-tailed t test. Average number of acceptors’ lysosomes per donor cell in control (2 ± 0.3) and in α-syn (2 ± 0.1) cocultures (right graph). Mean ± SEM. ns = not significant by Mann–Whitney U test. In CAD-HeLa coculture model, data were collected from 7 independent experiments in which 4 and 3 of them were labeled with anti-LAMP1 mouse and human antibodies, respectively. According to the experiment, in average, 100 acceptor or donor cells were analyzed for each condition per experiment. The data underlying this figure may be found in S1 Data. α-syn, α-synuclein; CAD, Cath.a-differentiated; Gal3, Galectin-3; LAMP, lysosome-associated membrane protein; LMP, lysosomal membrane permeabilization.CC0 · PubMed Central
Fig 11 Working model. (1) α-Syn fibrils localize to lysosomes following their uptake. (2) α-Syn fibrils induce LMP (i.e., recruit Gal3 to the ruptured lysosomes) in donor cells following their uptake, allowing their escape from lysosomes. (3) α-Syn fibrils interact with soluble α-syn and induce seeding in donor cells. (4) Following α-syn fibrils internalization, TFEB translocates to the nucleus. (5) Lysosomes (possibly under LMP, as their pH is higher and lysosomal activities is lower) having the α-syn fibrils move toward the cell periphery. (6) Peripheral lysosomes are not preferentially exocytosed. (7) Lysosomes having α-syn (both under LMP or not) are transferred to acceptor cells along with healthy lysosomes. (8) α-Syn fibrils induce LMP following their transfer to acceptor cells. (9) α-Syn fibrils induce further seeding following their transfer to acceptor cells. (10) Acceptor cells transfer healthy lysosomes to donors. α-syn, α-synuclein; Gal3, Galectin-3; LMP, lysosomal membrane permeabilization; TFEB, transcription factor EB; TNT, tunneling nanotube.
Fig 11 Working model. (1) α-Syn fibrils localize to lysosomes following their uptake. (2) α-Syn fibrils induce LMP (i.e., recruit Gal3 to the ruptured lysosomes) in donor cells following their uptake, allowing their escape from lysosomes. (3) α-Syn fibrils interact with soluble α-syn and induce seeding in donor cells. (4) Following α-syn fibrils internalization, TFEB translocates to the nucleus. (5) Lysosomes (possibly under LMP, as their pH is higher and lysosomal activities is lower) having the α-syn fibrils move toward the cell periphery. (6) Peripheral lysosomes are not preferentially exocytosed. (7) Lysosomes having α-syn (both under LMP or not) are transferred to acceptor cells along with healthy lysosomes. (8) α-Syn fibrils induce LMP following their transfer to acceptor cells. (9) α-Syn fibrils induce further seeding following their transfer to acceptor cells. (10) Acceptor cells transfer healthy lysosomes to donors. α-syn, α-synuclein; Gal3, Galectin-3; LMP, lysosomal membrane permeabilization; TFEB, transcription factor EB; TNT, tunneling nanotube.CC0 · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 144 references

Cited by

Items 101–133 of 133

Metadata

Authors
Dilsizoglu Senol, A., Samarani, M., Syan, S., Guardia, C. M., Nonaka, T., Liv, N., Latour-Lambert, P., Hasegawa, M., Klumperman, J., Bonifacino, J. S., & Zurzolo, C.
Affiliations
  • Institut Pasteur (FR)
  • National Institutes of Health (US)
  • Tokyo Metropolitan Institute of Medical Science (JP)
  • Utrecht University (NL)
Corresponding author
Zurzolo, Chiara
Venue
PLOS Biology
Published
2021-07-20
Volume
19
Issue
7
Pages
e3001287
ISSN
  • 1544-9173 (ISSN-L)
  • 1545-7885
OpenAlex
W3186717564
Cited by
134
References
143
Citations by year
2026: 29 · 2025: 24 · 2024: 36 · 2023: 17 · 2022: 22 · 2021: 5
FWCI
9.56
Type
journal article
Language
en
Open access
Locations
  • PLoS Biology (publishedVersion, public-domain)
  • PubMed Central (publishedVersion, public-domain)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Agence Nationale de la Recherche (ANR-16-CE16-0019-01)
  • Fondation pour la recherche médicale (FRM-2016-DEQ20160334896)
  • Intramural Program of NICHD (ZIA HD001607)
  • Grant-in-Aids for Scientific Research (JP26117005)
  • CREST, JST (JP18071300)
  • AMED Brain/MINDS (JP18dm0207019)
  • Brain Science Foundation
  • Netherlands Organization for Scientific Research (91216006)
  • France Alzheimer (S-FB17026, AAP SM 2017#1674)
  • Marie Skłodowska-Curie Action (H2020-MSCA-IF-2019 EU project 897378)
  • Euro-BioImaging grant (EuBI_AYDI109)
  • Institut Pasteur (INNOV 39-2019 Flash Start)
  • Association pour la Recherche sur la Sclérose Latérale Amyotrophique et autres Maladies du Motoneurone (appel d'offre 2016)
  • Fondation Vaincre Alzheimer (2016 / FR-16020)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
Keywords
alpha-synuclein fibrils, lysosomes, tunneling nanotubes, prion-like propagation, protein misfolding, Parkinson's disease, synucleinopathies, lysosomal membrane permeabilization, TFEB, intercellular transfer, Trojan horse
MeSH terms
Animals, Cell Membrane Permeability, Humans, Lysosomes, Microscopy, Electron, Protein Folding, Coculture Techniques, Nanotubes, alpha-Synuclein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.